These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 22298755

  • 1. Development and validation of a stability-indicating RP-UPLC method for the quantitative analysis of nabumetone in tablet dosage form.
    Sethi N, Anand A, Chandrul KK, Jain G, Srinivas KS.
    J Chromatogr Sci; 2012 Feb; 50(2):85-90. PubMed ID: 22298755
    [Abstract] [Full Text] [Related]

  • 2. Development and validation of UPLC method for determination of primaquine phosphate and its impurities.
    Dongre VG, Karmuse PP, Rao PP, Kumar A.
    J Pharm Biomed Anal; 2008 Jan 22; 46(2):236-42. PubMed ID: 18029132
    [Abstract] [Full Text] [Related]

  • 3. Development and validation of a stability-indicating RP-UPLC method for the quantitative analysis of sparfloxacin.
    Gupta H, Aqil M, Khar RK, Ali A, Sharma A, Chander P.
    J Chromatogr Sci; 2010 Jan 22; 48(1):1-6. PubMed ID: 20056027
    [Abstract] [Full Text] [Related]

  • 4. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N, Sangeetha D, Reddy SP.
    J Chromatogr Sci; 2012 Oct 22; 50(9):810-9. PubMed ID: 22661461
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms.
    Krishnaiah Ch, Vishnu Murthy M, Kumar R, Mukkanti K.
    J Pharm Biomed Anal; 2011 Mar 25; 54(4):667-73. PubMed ID: 21075576
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stability-indicating LC method for the simultaneous determination of lisinopril and hydrochlorothiazide.
    de Diego M, Soto J, Mennickent S.
    J Chromatogr Sci; 2014 Mar 25; 52(10):1193-7. PubMed ID: 24297524
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Validation and method development of Tadalafil in bulk and tablet dosage form by RP-HPLC.
    Bojanapu A, Subramaniam AT, Munusamy J, Dhanapal K, Chennakesavalu J, Sellappan M, Jayaprakash V.
    Drug Res (Stuttg); 2015 Feb 25; 65(2):82-5. PubMed ID: 24782284
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A New Rapid and Sensitive Stability-Indicating UPLC Assay Method for Tolterodine Tartrate: Application in Pharmaceuticals, Human Plasma and Urine Samples.
    Yanamandra R, Vadla CS, Puppala U, Patro B, Murthy YL, Ramaiah PA.
    Sci Pharm; 2012 Feb 25; 80(1):101-14. PubMed ID: 22396907
    [Abstract] [Full Text] [Related]

  • 17. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M, Azougagh M, Amood A L-Kamarany M, Bouchafra H, Cherrah Y, Bouklouze A.
    Ann Pharm Fr; 2014 Jul 25; 72(4):244-55. PubMed ID: 24997886
    [Abstract] [Full Text] [Related]

  • 18. A validated stability-indicating UPLC method for the determination of impurities in Maraviroc.
    Chilukuri M, Hussainreddy K, Narayanareddy P, Venkataramana M.
    J Chromatogr Sci; 2014 Aug 25; 52(7):609-16. PubMed ID: 23825352
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
    Nageswari A, Reddy KV, Mukkanti K.
    J Pharm Biomed Anal; 2012 Jul 25; 66():109-15. PubMed ID: 22502910
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.